Tumour markers and cytological methods for diagnosis of cholangiocarcinoma | Download Table
Establishment and Characterization of a Cholangiocarcinoma Cell Line from a Thai Patient with Intrahepatic Bile Duct Cancer
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma | HTML
Predictive value of multiple serum tumor markers | CMAR
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
![PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/942919bec9429e21c4d8ed2b634a865a13da7cad/3-Table2-1.png "PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar")
PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar
Surgical management of cholangiocarcinoma
Gastrointestinal cancers Notes: Diagrams & Illustrations | Osmosis
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
Cholangiocarcinoma - YouTube
Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease. | Semantic Scholar
Pathology of Cholangiocarcinoma and Combined Hepatocellular‐ Cholangiocarcinoma - Krishna - 2021 - Clinical Liver Disease - Wiley Online Library
Cancers | Free Full-Text | Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma | HTML
Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis - ScienceDirect
March 2012 Residency Program Case of the Month | Department of Pathology UC Davis Health System
Cholangiocarcinoma
Phenotype markers of candidate cholangiocarcinoma cells of origin | Download Table
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect
Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis | BMC Cancer | Full Text
Biliary Tract Cancers | NEJM
Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Patient Version - Siteman Cancer Center
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Surface Markers of Cancer Stem Cells in Cholangiocarcinoma (CCA). | Download Scientific Diagram
Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
KoreaMed Synapse
